Hester A. Kruseman-De Groot

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 44 publications

Biological and clinical characteristics of ETV6::RUNX1-like ALL.

Biological and clinical characteristics of ETV6::RUNX1-like ALL.

Journal: HemaSphere

Published: August 28, 2025

Bone marrow lymphocyte dynamics during chemotherapy in pediatric acute myeloid leukemia.

Bone marrow lymphocyte dynamics during chemotherapy in pediatric acute myeloid leukemia.

Journal: HemaSphere

Published: May 04, 2025

Immunoglobulin prophylaxis prevents hospital admissions for fever in pediatric acute lymphoblastic leukemia: results of a multicenter randomized trial.

Immunoglobulin prophylaxis prevents hospital admissions for fever in pediatric acute lymphoblastic leukemia: results of a multicenter randomized trial.

Journal: Haematologica

Published: March 08, 2024

A multidimensional analysis reveals distinct immune phenotypes and the composition of immune aggregates in pediatric acute myeloid leukemia.

A multidimensional analysis reveals distinct immune phenotypes and the composition of immune aggregates in pediatric acute myeloid leukemia.

Journal: Leukemia

Published: February 28, 2024

Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL: A Dutch Childhood Oncology Group ALL11 Randomized Trial.

Continuous PEGasparaginase Dosing Reduces Hypersensitivity Reactions in Pediatric ALL: A Dutch Childhood Oncology Group ALL11 Randomized Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 02, 2024

Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk.

Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk.

Journal: Cancer discovery

Published: December 06, 2023

Biologic and clinical features of childhood gamma delta T-ALL: identification of STAG2/LMO2 γδ T-ALL as an extremely high risk leukemia in the very young.

Biologic and clinical features of childhood gamma delta T-ALL: identification of STAG2/LMO2 γδ T-ALL as an extremely high risk leukemia in the very young.

Journal: medRxiv : the preprint server for health sciences

Published: November 21, 2023

A multidimensional analysis reveals distinct immune phenotypes and the composition of immune aggregates in pediatric acute myeloid leukemia.

A multidimensional analysis reveals distinct immune phenotypes and the composition of immune aggregates in pediatric acute myeloid leukemia.

Journal: medRxiv : the preprint server for health sciences

Published: November 14, 2023

Tyrosine kinase inhibitor resistance in de novo BCR::ABL1-positive BCP-ALL beyond kinase domain mutations.

Tyrosine kinase inhibitor resistance in de novo BCR::ABL1-positive BCP-ALL beyond kinase domain mutations.

Journal: Blood advances

Published: November 13, 2023

Tyrosine kinase inhibitor response of ABL-class acute lymphoblastic leukemia: the role of kinase type and SH3 domain.

Tyrosine kinase inhibitor response of ABL-class acute lymphoblastic leukemia: the role of kinase type and SH3 domain.

Journal: Blood

Published: November 01, 2023

Are measurable residual disease results after consolidation therapy useful in children with acute lymphoblastic leukemia?

Are measurable residual disease results after consolidation therapy useful in children with acute lymphoblastic leukemia?

Journal: Leukemia

Published: October 04, 2023

Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia.

Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia.

Journal: Blood advances

Published: September 24, 2023

Showing 1-12 of 44

Last Updated: 09/26/2026